Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.
Joseph Volpicelli, MD, PhD
Advertisement
Articles by Joseph Volpicelli, MD, PhD
Advertisement
Latest Updated Articles
- Heterogeneity of Nonadherent Buprenorphine Patients: Subgroup Characteristics and Outcomes
Published: June 27th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
How Clinician-Led Partnerships Strengthen Post-Acute Care
4
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
5
